Inflammation markers in coronary heart disease patients with aortic valve stenosis

Raised level of lipoproteide (a) (Lpa) is an independent risk factor of coronary heart disease (CHD) and is also a monogenic predictor (there is growth of prevalence) of aortic stenosis (AS) with the increase of Lpa in population. Lysophosphatide acid, secreted by an enzyme with phospholipase D acti...

Full description

Bibliographic Details
Main Authors: O. I. Afansieva, N. A. Tmojan, E. A. Klesareva, O. A. Razova, M. A. Afanasieva, А. L. Burdeynaya, M. A. Saidova, M. V. Ezhov, S. N. Pokrovsky
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2018-09-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/2865
_version_ 1826561200495788032
author O. I. Afansieva
N. A. Tmojan
E. A. Klesareva
O. A. Razova
M. A. Afanasieva
А. L. Burdeynaya
M. A. Saidova
M. V. Ezhov
S. N. Pokrovsky
author_facet O. I. Afansieva
N. A. Tmojan
E. A. Klesareva
O. A. Razova
M. A. Afanasieva
А. L. Burdeynaya
M. A. Saidova
M. V. Ezhov
S. N. Pokrovsky
author_sort O. I. Afansieva
collection DOAJ
description Raised level of lipoproteide (a) (Lpa) is an independent risk factor of coronary heart disease (CHD) and is also a monogenic predictor (there is growth of prevalence) of aortic stenosis (AS) with the increase of Lpa in population. Lysophosphatide acid, secreted by an enzyme with phospholipase D activity — autotaxin (ATX) is an inflammatory mediator. Humoral immunity involvement in inflammatory processes in coronary arteries and aortic valve might present with the presence of circulating autoantibodies and shifts in the values of cellular immunity.Aim. To assess the relation of Lpa, ATX and immunity with the presence of AS in chronic CHD patients.Material and methods. To a single moment study, 210 patients were included, with chronic CHD. Patients were selected to two groups by the presence (main group, n=47) or absence (controls, n=163) of degenerative AS by echocardiography. Patients were taking standard CHD therapy. All patients underwent clinical blood count, lipids concentration and Lpa. ATX, C-reactive protein, autoantibodies to ApoB-100 lipoproteides and their Cu2+-oxidated modifications. Phenotypes of apoprotein (a) were assessed in 168 patients.Results. CHD patients with degenerative AS were older (74,2±7,8 versus 67,6±9,4 y., p=0,0007), but did not differ by the clinical and biochemical characteristics, level of Lpa and high sensitive С-reactive protein (hsCRP). Concentration of АТХ in plasma was significantly higher (554±95 and 497±105 ng/mL, p=0,001), but the level of IgM autoantibodies against the oxidated lipoproteid (а) (oxLpa) — significantly lower (10,8 [7,9;15,1] and 13,4 [11,4;16,7] relative units, p<0,001) in the main group comparing to control. Neutrophilic-lymphocytal index also differed significantly in the AS group and non-AS (2,04 [1,56;3,14] and 1,72 [1,39;2,14]). By the results of logistic analysis, the age, level of ATX, titer of autoantibodies to oxLpa and neutrophilic-limphocytal index were significant independent predictors of the degenerative AS.Conclusion. In the patients with chronic CHD, undergoing statin therapy, the levels of ATX, autoantiboides IgM against the oxLpa and relation of neutrophils to lymphocytes, but not the concentration of Lpa and low molecular phenotype of apo(a), were related to AS presence.
first_indexed 2024-04-09T20:46:59Z
format Article
id doaj.art-d87ad72251164e36acb2fd4bf04f1261
institution Directory Open Access Journal
issn 1560-4071
2618-7620
language Russian
last_indexed 2025-03-14T09:28:24Z
publishDate 2018-09-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj.art-d87ad72251164e36acb2fd4bf04f12612025-03-02T11:42:45Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202018-09-0109172210.15829/1560-4071-2018-9-17-222434Inflammation markers in coronary heart disease patients with aortic valve stenosisO. I. Afansieva0N. A. Tmojan1E. A. Klesareva2O. A. Razova3M. A. Afanasieva4А. L. Burdeynaya5M. A. Saidova6M. V. Ezhov7S. N. Pokrovsky8National Medical Research Center of Cardiology of the Ministry of HealthNational Medical Research Center of Cardiology of the Ministry of HealthNational Medical Research Center of Cardiology of the Ministry of HealthNational Medical Research Center of Cardiology of the Ministry of HealthNational Medical Research Center of Cardiology of the Ministry of HealthNational Medical Research Center of Cardiology of the Ministry of HealthNational Medical Research Center of Cardiology of the Ministry of HealthNational Medical Research Center of Cardiology of the Ministry of HealthNational Medical Research Center of Cardiology of the Ministry of HealthRaised level of lipoproteide (a) (Lpa) is an independent risk factor of coronary heart disease (CHD) and is also a monogenic predictor (there is growth of prevalence) of aortic stenosis (AS) with the increase of Lpa in population. Lysophosphatide acid, secreted by an enzyme with phospholipase D activity — autotaxin (ATX) is an inflammatory mediator. Humoral immunity involvement in inflammatory processes in coronary arteries and aortic valve might present with the presence of circulating autoantibodies and shifts in the values of cellular immunity.Aim. To assess the relation of Lpa, ATX and immunity with the presence of AS in chronic CHD patients.Material and methods. To a single moment study, 210 patients were included, with chronic CHD. Patients were selected to two groups by the presence (main group, n=47) or absence (controls, n=163) of degenerative AS by echocardiography. Patients were taking standard CHD therapy. All patients underwent clinical blood count, lipids concentration and Lpa. ATX, C-reactive protein, autoantibodies to ApoB-100 lipoproteides and their Cu2+-oxidated modifications. Phenotypes of apoprotein (a) were assessed in 168 patients.Results. CHD patients with degenerative AS were older (74,2±7,8 versus 67,6±9,4 y., p=0,0007), but did not differ by the clinical and biochemical characteristics, level of Lpa and high sensitive С-reactive protein (hsCRP). Concentration of АТХ in plasma was significantly higher (554±95 and 497±105 ng/mL, p=0,001), but the level of IgM autoantibodies against the oxidated lipoproteid (а) (oxLpa) — significantly lower (10,8 [7,9;15,1] and 13,4 [11,4;16,7] relative units, p<0,001) in the main group comparing to control. Neutrophilic-lymphocytal index also differed significantly in the AS group and non-AS (2,04 [1,56;3,14] and 1,72 [1,39;2,14]). By the results of logistic analysis, the age, level of ATX, titer of autoantibodies to oxLpa and neutrophilic-limphocytal index were significant independent predictors of the degenerative AS.Conclusion. In the patients with chronic CHD, undergoing statin therapy, the levels of ATX, autoantiboides IgM against the oxLpa and relation of neutrophils to lymphocytes, but not the concentration of Lpa and low molecular phenotype of apo(a), were related to AS presence.https://russjcardiol.elpub.ru/jour/article/view/2865lipoproteide (a)apoprotein (a)aortic valve stenosisautotaxinautoantibodiesneuthrophilic-lymphocytal relation
spellingShingle O. I. Afansieva
N. A. Tmojan
E. A. Klesareva
O. A. Razova
M. A. Afanasieva
А. L. Burdeynaya
M. A. Saidova
M. V. Ezhov
S. N. Pokrovsky
Inflammation markers in coronary heart disease patients with aortic valve stenosis
Российский кардиологический журнал
lipoproteide (a)
apoprotein (a)
aortic valve stenosis
autotaxin
autoantibodies
neuthrophilic-lymphocytal relation
title Inflammation markers in coronary heart disease patients with aortic valve stenosis
title_full Inflammation markers in coronary heart disease patients with aortic valve stenosis
title_fullStr Inflammation markers in coronary heart disease patients with aortic valve stenosis
title_full_unstemmed Inflammation markers in coronary heart disease patients with aortic valve stenosis
title_short Inflammation markers in coronary heart disease patients with aortic valve stenosis
title_sort inflammation markers in coronary heart disease patients with aortic valve stenosis
topic lipoproteide (a)
apoprotein (a)
aortic valve stenosis
autotaxin
autoantibodies
neuthrophilic-lymphocytal relation
url https://russjcardiol.elpub.ru/jour/article/view/2865
work_keys_str_mv AT oiafansieva inflammationmarkersincoronaryheartdiseasepatientswithaorticvalvestenosis
AT natmojan inflammationmarkersincoronaryheartdiseasepatientswithaorticvalvestenosis
AT eaklesareva inflammationmarkersincoronaryheartdiseasepatientswithaorticvalvestenosis
AT oarazova inflammationmarkersincoronaryheartdiseasepatientswithaorticvalvestenosis
AT maafanasieva inflammationmarkersincoronaryheartdiseasepatientswithaorticvalvestenosis
AT alburdeynaya inflammationmarkersincoronaryheartdiseasepatientswithaorticvalvestenosis
AT masaidova inflammationmarkersincoronaryheartdiseasepatientswithaorticvalvestenosis
AT mvezhov inflammationmarkersincoronaryheartdiseasepatientswithaorticvalvestenosis
AT snpokrovsky inflammationmarkersincoronaryheartdiseasepatientswithaorticvalvestenosis